Graphite Bio Inc reports results for the quarter ended in June - Earnings Summary

LENZ Therapeutics

13/08/2021 01:02

* Graphite Bio Inc  GRPH.OQ  reported a quarterly adjusted loss
of $3.45​​ per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of
$1.10 per share.
* Reported revenue was zero​;  analysts expected zero. 
* Graphite Bio Inc's reported EPS for the quarter was a loss of
$3.45​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Graphite Bio Inc shares had fallen by 28.3% this quarter.
* The company reported a quarterly loss of $17.53 million.
* Wall Street's median 12-month price target for Graphite Bio
Inc is $34.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 13 at 12:02 a.m.  ​All
figures in US dollars unless otherwise stated